N4 Pharma Balance Sheet Health
Financial Health criteria checks 6/6
N4 Pharma has a total shareholder equity of £1.2M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £1.3M and £81.7K respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | n/a |
| Cash | UK£1.03m |
| Equity | UK£1.19m |
| Total liabilities | UK£81.73k |
| Total assets | UK£1.28m |
Recent financial health updates
Companies Like N4 Pharma (LON:N4P) Are In A Position To Invest In Growth
Oct 11
Here's Why We're Not Too Worried About N4 Pharma's (LON:N4P) Cash Burn Situation
Jul 06Companies Like N4 Pharma (LON:N4P) Can Afford To Invest In Growth
Dec 07
Recent updates
Companies Like N4 Pharma (LON:N4P) Are In A Position To Invest In Growth
Oct 11Here's Why We're Not Too Worried About N4 Pharma's (LON:N4P) Cash Burn Situation
Jul 06Should Shareholders Have Second Thoughts About A Pay Rise For N4 Pharma Plc's (LON:N4P) CEO This Year?
Mar 18Here's What We Think About N4 Pharma's (LON:N4P) CEO Pay
Mar 01Companies Like N4 Pharma (LON:N4P) Can Afford To Invest In Growth
Dec 07Financial Position Analysis
Short Term Liabilities: N4P's short term assets (£1.2M) exceed its short term liabilities (£81.7K).
Long Term Liabilities: N4P has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: N4P is debt free.
Reducing Debt: N4P has no debt compared to 5 years ago when its debt to equity ratio was 4.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: N4P has sufficient cash runway for 10 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: N4P is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.